Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
red violet to Present at the B. Riley 24th Annual Institutional Investor Conference
-
Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference
-
PDS Biotech to Participate in Upcoming May 2024 Investor Conferences
-
Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
-
RAPT Therapeutics Reports First Quarter 2024 Financial Results
-
Creative Realities to Restructure Debt Through Revolving Credit Facility
-
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
-
Shoals Technologies Group Expands Leadership Team with Key Appointments in International Business and Investor Relations
-
Rush Street Interactive to Participate at the Needham Technology, Media, & Consumer Conference
-
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
-
ACV to Participate in Upcoming Investor Conferences
-
Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
-
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
-
Binance Labs Incubated UXUY Secures $7M Pre-A Round Fundraising, Surpasses $10 Million Total Funding Milestone
-
Acorn’s Q1’24 EPS Improves to $0.03 vs. ($0.03) Loss Per Share on Continued Growth in Remote Monitoring and Control Hardware and Services Revenue
-
illumin Reports First Quarter 2024 Financial Results
-
Mounting Evidence that use of the Mental Health Collaborative Care Model is Associated with Reductions in Total Healthcare Costs
-
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
-
Knight Therapeutics Reports First Quarter 2024 Results
-
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America
-
Kelly Reports First-Quarter 2024 Earnings
-
Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
-
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
-
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Whole Earth Brands Reports First Quarter 2024 Results
-
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
-
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
-
Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
-
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
-
Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
-
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
-
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
-
Cronos Group Reports 2024 First Quarter Results
-
Destination XL Group, Inc. to Announce First Quarter 2024 Financial Results on May 30, 2024
-
SPS Commerce Acquires Traverse Systems
-
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alternatives
-
Zevra Therapeutics to Participate at Upcoming Investor Events
-
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
-
Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2024
-
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Eos Energy Enterprises Announces Participation in Upcoming Investor Conferences
-
Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update
-
Verrica Pharmaceuticals to Present at Upcoming Investor Conferences
-
Vital Farms Reports First Quarter 2024 Financial Results
-
Kingsoft Cloud to Report First Quarter 2024 Financial Results on May 22, 2024
-
Boussard & Gavaudan Investment Management LLP: Form 8.3 - Network International Holdings PLC
-
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
Man Group PLC : Form 8.3 - Barratt Developments plc


